Literature DB >> 31255442

Significant improvement in postoperative and 1-year mortality after colorectal cancer surgery in recent years.

S H J Ketelaers1, R G Orsini1, J W A Burger1, G A P Nieuwenhuijzen1, H J T Rutten2.   

Abstract

BACKGROUND: In earlier studies an association between older patients and higher morbidity and mortality after colorectal surgery is shown, especially in the first postoperative year. We conducted this study to investigate if there is improvement in postoperative morbidity and mortality in senior CRC patients over time.
MATERIALS AND METHODS: All patients, except those with distant metastasis, who received curative CRC surgery between 2006 and 2017 in the Catharina Hospital (Eindhoven, the Netherlands) were selected retrospectively. Differences in mortality and relative survival between different age groups (<75 and ≥ 75 years), period of surgery (2006-2012 and 2013-2017) and type of tumor (colon and rectum) were investigated.
RESULTS: In total 2018 patients, of whom 57.4% is male, were selected (n = 1037 colon and n = 981 rectum). 615 (30.5%) patients were ≥75 years old. For electively treated CRC patients aged ≥75 years 30- and 90-day mortality improved from 5.8% to 1.2% (p = 0.004) and 9.1% to 4.6% (p = 0.043) respectively, in favour of the latest time period. Relative one-year survival rates of all electively treated CRC patients were not significantly different between younger and older patients in the latest time period (95.5% vs. 94.3%, p = n.s.).
CONCLUSIONS: This study shows significant improvement in postoperative morbidity and mortality over time for both age and treatment groups. Relative survival rates improved especially for older patients and no significant differences were seen between both age groups. Senior CRC patients should not be withheld curative treatment based on age or comorbidities alone.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Colon cancer; Curative surgery; Morbidity; Rectal cancer; Senior patients; Survival

Mesh:

Year:  2019        PMID: 31255442     DOI: 10.1016/j.ejso.2019.06.017

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  5 in total

1.  Colorectal cancer surgery in elderly patients 80 years and older: a comparison with younger age groups.

Authors:  Toshiro Ogata; Naohiro Yoshida; Yoshihiko Sadakari; Ayako Iwanaga; Hiroyuki Nakane; Kazuma Okawara; Kayoko Endo; Kazuhisa Kaneshiro; Gentaro Hirokata; Takeshi Aoyagi; Hiroji Shima; Masahiko Taniguchi
Journal:  J Gastrointest Oncol       Date:  2022-02

2.  Developing prediction models for short-term mortality after surgery for colorectal cancer using a Danish national quality assurance database.

Authors:  Karoline B Bräuner; Andreas W Rosen; Adamantia Tsouchnika; Julie S Walbech; Mikail Gögenur; Viviane A Lin; Johan S R Clausen; Ismail Gögenur
Journal:  Int J Colorectal Dis       Date:  2022-07-18       Impact factor: 2.796

Review 3.  A Multidisciplinary Approach for the Personalised Non-Operative Management of Elderly and Frail Rectal Cancer Patients Unable to Undergo TME Surgery.

Authors:  Stijn H J Ketelaers; Anne Jacobs; An-Sofie E Verrijssen; Jeltsje S Cnossen; Irene E G van Hellemond; Geert-Jan M Creemers; Ramon-Michel Schreuder; Harm J Scholten; Jip L Tolenaar; Johanne G Bloemen; Harm J T Rutten; Jacobus W A Burger
Journal:  Cancers (Basel)       Date:  2022-05-11       Impact factor: 6.575

Review 4.  A Systematic Review Comparing Emergency Resection and Staged Treatment for Curable Obstructing Right-Sided Colon Cancer.

Authors:  Jeske R E Boeding; Winesh Ramphal; Arjen M Rijken; Rogier M P H Crolla; Cornelis Verhoef; Paul D Gobardhan; Jennifer M J Schreinemakers
Journal:  Ann Surg Oncol       Date:  2020-10-16       Impact factor: 5.344

5.  Contact X-ray Brachytherapy for Older or Inoperable Rectal Cancer Patients: Short-Term Oncological and Functional Follow-Up.

Authors:  Petra A Custers; Barbara M Geubels; Inge L Huibregtse; Femke P Peters; Ellen G Engelhardt; Geerard L Beets; Corrie A M Marijnen; Monique E van Leerdam; Baukelien van Triest
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.